A2 share price frenzy – but is the US formula market worth it?

A2 share price frenzy – but is the US formula market worth it?
The American dream may not be worth it for A2. (Image: Getty)
Jenny Ruth
Some investors believe accessing the US infant formula market would be a big deal for Fonterra and the A2 Milk Company, and trading in A2’s shares last week highlighted that fact.An Australian Financial Review (AFR) journalist got a little over her skis on Tuesday and published a story saying A2 could get US Food & Drug Administration (FDA) approval “as soon as this week”.Both Fonterra and A2 have been waiting for this approval since they applied in late May after the FDA made public it was looking to facilitate infant for...

More Primary Sector

My Net Worth: Garry Diack, CEO of Ravensdown
Primary Sector

My Net Worth: Garry Diack, CEO of Ravensdown

Strongman held him in Fiji after the coup – he was needed to play cricket for the Army.

Akaroa King Salmon boss steps down after 23 years
Primary Sector

Akaroa King Salmon boss steps down after 23 years

Scotsman Stewart Hawthorn takes over from Duncan Bates as Akaroa King Salmon CEO.

John Anthony 24 Jan 2025
Synlait Milk expecting to return to profitability
Primary Sector

Synlait Milk expecting to return to profitability

Last year, the dairy processor reported a net loss of $182.1m.

Riley Kennedy 24 Jan 2025
LIC's revenue up 8% in the first half
Primary Sector

LIC's revenue up 8% in the first half

Dairy genetics firm is looking at its future strategy.

Riley Kennedy 23 Jan 2025